US 8853271
Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid
granted A61KA61K2800/782A61K31/19
Quick answer
US patent 8853271 (Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid) held by China Medical University expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- China Medical University
- Grant date
- Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2800/782, A61K31/19, A61K8/63, A61P